Wellington Management Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-800,624
| Closed | -$13.4M | – | 2033 |
|
|
2020
Q2 | $13.4M | Sell |
800,624
-114,135
| -12% | -$1.91M | ﹤0.01% | 1010 |
|
|
2020
Q1 | $13.2M | Sell |
914,759
-1,579,374
| -63% | -$22.8M | ﹤0.01% | 975 |
|
|
2019
Q4 | $83.5M | Sell |
2,494,133
-156,736
| -6% | -$5.25M | 0.02% | 612 |
|
|
2019
Q3 | $55.5M | Buy |
2,650,869
+843,597
| +47% | +$17.7M | 0.01% | 699 |
|
|
2019
Q2 | $37.6M | Buy |
1,807,272
+10,791
| +0.6% | +$225K | 0.01% | 839 |
|
|
2019
Q1 | $40.2M | Sell |
1,796,481
-64,470
| -3% | -$1.44M | 0.01% | 816 |
|
|
2018
Q4 | $44.5M | Buy |
1,860,951
+190,617
| +11% | +$4.56M | 0.01% | 748 |
|
|
2018
Q3 | $45.6M | Sell |
1,670,334
-177,811
| -10% | -$4.85M | 0.01% | 830 |
|
|
2018
Q2 | $49.7M | Sell |
1,848,145
-213,047
| -10% | -$5.73M | 0.01% | 794 |
|
|
2018
Q1 | $65.6M | Buy |
2,061,192
+2,020,789
| +5,002% | +$64.3M | 0.01% | 695 |
|
|
2017
Q4 | $1.53M | Buy |
40,403
+30,105
| +292% | +$1.14M | ﹤0.01% | 1793 |
|
|
2017
Q3 | $255K | Buy |
+10,298
| New | +$255K | ﹤0.01% | 2088 |
|
|
2017
Q2 | – | Sell |
-2,316,553
| Closed | -$50.3M | – | 2304 |
|
|
2017
Q1 | $50.3M | Buy |
2,316,553
+2,004,023
| +641% | +$43.5M | 0.01% | 722 |
|
|
2016
Q4 | $6.39M | Buy |
+312,530
| New | +$6.39M | ﹤0.01% | 1325 |
|